Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Thrombocytopenia
•
Hematology
•
Benign Hematology
•
ITP
Does a robust response to IVIG establish the diagnosis of ITP in an elderly patient, where you might otherwise consider a bone marrow biopsy to rule out other hematological disorders?
Related Questions
How would you manage ITP in patients who develop cirrhosis and hemorrhage?
Are there any known contraindications or scenarios in which using antifibrinolytics would cause worsening of bleeding symptoms?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
How frequently would you consider IV iron treatment for ongoing iron loss and severe iron deficiency anemia?
Can TPO agonists, like avatrombopag or lusutrombopag, be used for patients with chronic thrombocytopenia and new acute portal vein thrombosis?
Do you routinely check serum phosphorus levels after IV iron therapy?
Would you consider long term avatrombopag use in patients with cirrhosis requiring higher platelet counts for medical therapy?
Are there data to support full-dose anticoagulation added to an antiplatelet in recurrent peripheral arterial thrombosis requiring revascularization and stenting?
Would you evaluate for thrombophilia in patients with incidental splenic infarcts in the setting of known cirrhosis, portal hypertension, and splenomegaly?
Can lupus anticoagulant be positive despite a normal aPTT?
